Christopher Gibson - 03 Apr 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
03 Apr 2024
Net transactions value
-$1,160,900
Form type
4
Filing time
05 Apr 2024, 17:44:51 UTC
Previous filing
01 Apr 2024
Next filing
03 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Gift $0 -25,000 -2.4% $0.000000 1,018,524 03 Apr 2024 Direct F1
transaction RXRX Class A Common Stock Sale $353,600 -40,000 -3.9% $8.84 978,524 03 Apr 2024 Direct F1
transaction RXRX Class A Common Stock Sale $360,800 -40,000 -4.1% $9.02 938,524 04 Apr 2024 Direct F1
transaction RXRX Class A Common Stock Conversion of derivative security $0 +25,000 $0.000000 25,000 03 Apr 2024 by Gibson Family Trust F1, F2, F3
transaction RXRX Class A Common Stock Sale $221,000 -25,000 -100% $8.84 0 03 Apr 2024 by Gibson Family Trust F1, F3
transaction RXRX Class A Common Stock Conversion of derivative security $0 +25,000 $0.000000 25,000 04 Apr 2024 By LAHWRAN-3 LLC F1, F2, F4
transaction RXRX Class A Common Stock Sale $225,500 -25,000 -100% $9.02 0 04 Apr 2024 by LAHWRAN-3 LLC F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -25,000 -27% $0.000000 67,875 03 Apr 2024 Class A Common Stock 25,000 $0.000000 by Gibson Family Trust F1, F2, F3, F5
transaction RXRX Class B Common Stock Conversion of derivative security $0 -25,000 -4.9% $0.000000 486,000 04 Apr 2024 Class A Common Stock 25,000 $0.000000 by LAHWRAN-3 LLC F1, F2, F4, F5
holding RXRX Class B Common Stock 388,000 03 Apr 2024 Class A Common Stock 0 $0.000000 by LAHWRAN-4 LLC F5, F6
holding RXRX Stock Option (Right to Buy) 312,500 03 Apr 2024 Class A Common Stock 0 $2.48 Direct F7
holding RXRX Stock Option (Right to Buy) 399,002 03 Apr 2024 Class A Common Stock 0 $11.40 Direct F8
holding RXRX Stock Option (Right to Buy) 813,600 03 Apr 2024 Class A Common Stock 0 $8.55 Direct F9
holding RXRX Stock Option (Right to Buy) 5,436 03 Apr 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 666,898 03 Apr 2024 Class A Common Stock 0 $10.09 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023
F2 Represents the conversion of Class B Common Stock into Class A Common Stock.
F3 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F4 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F5 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F6 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F7 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F8 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F9 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.